Exploratory Study of Farletuzumab to Treat Resectable, Non-functioning Pituitary Adenomas
Clinical trial NCT01203618 · WITHDRAWN
Trial details
- NCT number
- NCT01203618
- Sponsor
- Morphotek
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-01
- Primary completion
- 2013-06-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.